Healthequity (NASDAQ:HQY) PT Lowered to $80.00

Healthequity (NASDAQ:HQY) had its price objective reduced by SunTrust Banks to $80.00 in a report released on Monday morning, The Fly reports. They currently have a buy rating on the stock.

Several other research analysts have also recently commented on the company. JPMorgan Chase & Co. set a $80.00 target price on Healthequity and gave the stock an overweight rating in a research note on Wednesday, June 5th. Wells Fargo & Co lowered their target price on Healthequity from $80.00 to $76.00 and set an outperformer rating for the company in a research note on Wednesday, September 4th. Zacks Investment Research raised Healthequity from a strong sell rating to a hold rating in a research note on Tuesday, May 21st. Citigroup reissued a buy rating on shares of Healthequity in a research note on Friday, June 28th. Finally, BidaskClub cut Healthequity from a hold rating to a sell rating in a research note on Saturday, September 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Healthequity currently has an average rating of Buy and an average target price of $80.46.

Shares of NASDAQ HQY opened at $57.78 on Monday. Healthequity has a twelve month low of $50.29 and a twelve month high of $101.58. The company has a current ratio of 22.98, a quick ratio of 15.59 and a debt-to-equity ratio of 0.04. The stock has a fifty day simple moving average of $67.10 and a 200-day simple moving average of $70.62. The stock has a market capitalization of $3.76 billion, a PE ratio of 60.82, a PEG ratio of 3.13 and a beta of 1.55.



Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.10. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The business had revenue of $86.60 million during the quarter, compared to analysts’ expectations of $85.33 million. During the same period in the previous year, the firm posted $0.36 earnings per share. The company’s revenue was up 21.8% on a year-over-year basis. On average, equities analysts predict that Healthequity will post 0.93 earnings per share for the current year.

In other Healthequity news, CFO Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $60.82, for a total transaction of $243,280.00. Following the completion of the sale, the chief financial officer now directly owns 50,100 shares of the company’s stock, valued at approximately $3,047,082. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Delano Ladd sold 6,875 shares of Healthequity stock in a transaction dated Monday, July 22nd. The stock was sold at an average price of $80.00, for a total value of $550,000.00. Following the sale, the executive vice president now directly owns 17,833 shares of the company’s stock, valued at $1,426,640. The disclosure for this sale can be found here. Insiders have sold a total of 37,899 shares of company stock valued at $2,751,451 over the last three months. 3.70% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in HQY. BlackRock Inc. lifted its holdings in shares of Healthequity by 13.1% in the 2nd quarter. BlackRock Inc. now owns 7,268,685 shares of the company’s stock valued at $475,373,000 after purchasing an additional 840,177 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Healthequity by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 5,646,295 shares of the company’s stock valued at $369,268,000 after purchasing an additional 138,020 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Healthequity by 13.7% in the 2nd quarter. Invesco Ltd. now owns 2,140,851 shares of the company’s stock valued at $140,012,000 after purchasing an additional 258,769 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in shares of Healthequity by 13.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,057,831 shares of the company’s stock valued at $134,582,000 after purchasing an additional 250,692 shares during the last quarter. Finally, Wasatch Advisors Inc. lifted its holdings in shares of Healthequity by 22.6% in the 1st quarter. Wasatch Advisors Inc. now owns 2,038,929 shares of the company’s stock valued at $150,840,000 after purchasing an additional 376,461 shares during the last quarter. 94.77% of the stock is owned by institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: Buyback

The Fly

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.